Retour sur lavenir.net
   DEME GROUP 169.000 € (+0,12 %)     CELYAD ONCOLOGY 0.250 € (-9,42 %)     WDP 22.400 € (+1,36 %)     AB INBEV 72.520 € (+1,45 %)     VGP 82.700 € (+1,97 %)     FAGRON 23.700 € (-0,63 %)     ENERGYVISION 14.840 € (+0,27 %)     XIOR 27.950 € (0,00 %)     NYXOAH 1.368 € (-1,16 %)     ELIA GROUP 139.800 € (+1,60 %)     KBC 122.650 € (+0,25 %)     BPOST 1.560 € (-0,64 %)     ORANGE BELGIUM 21.800 € (+0,46 %)     TESSENDERLO 20.900 € (+1,95 %)     ECONOCOM GROUP 1.465 € (0,00 %)     COLRUYT 38.120 € (+0,47 %)     ONTEX GROUP 2.265 € (+2,49 %)     CFE 11.500 € (+0,44 %)     IBA 16.680 € (-0,36 %)     VIOHALCO 17.680 € (+2,67 %)     TEXAF 40.400 € (-2,42 %)     SHURGARD 25.550 € (+1,39 %)     KBC ANCORA 87.100 € (-0,11 %)     UCB 243.300 € (-0,25 %)     TINC 11.340 € (+1,80 %)     CIE BOIS SAUVAGE 310.000 € (+2,99 %)     FLUXYS BELGIUM D 20.000 € (+2,56 %)     SOLVAY 26.140 € (+0,62 %)     SOLVAC NOM(RETAIL) 77.500 € (+3,33 %)     PROXIMUS 6.135 € (+1,24 %)     AGFA-GEVAERT 0.400 € (+1,39 %)     GBL 77.850 € (+0,84 %)     ONWARD MEDICAL 2.475 € (-0,40 %)     SIPEF 93.900 € (+1,62 %)     ACKERMANS V.HAAREN 269.800 € (+0,45 %)     JENSEN-GROUP 85.800 € (+1,90 %)     CENERGY 21.560 € (+1,41 %)     BELYSSE GROUP 0.510 € (+6,25 %)     AGEAS 72.050 € (+1,77 %)     TUBIZE-FIN 210.000 € (+0,48 %)     VAN DE VELDE 30.100 € (+1,69 %)     HOME INVEST BE. 19.860 € (+2,06 %)     BREDERODE 103.000 € (0,00 %)     WERELDHAVE BELGIUM 53.200 € (+1,53 %)     VASTNED 29.400 € (+0,34 %)     ARGENX SE 758.400 € (-0,24 %)     AEDIFICA 70.400 € (+0,72 %)     RECTICEL 12.120 € (+0,83 %)     CAMPINE 207.000 € (+0,49 %)     AZELIS GROUP 10.480 € (-0,29 %)     ASCENCIO 51.600 € (+0,19 %)     GIMV 44.850 € (+0,67 %)     D'IETEREN GROUP 176.000 € (+2,09 %)     RETAIL ESTATES 68.500 € (+1,33 %)     EVS 27.000 € (+0,37 %)     BARCO 8.000 € (+2,63 %)     DECEUNINCK 2.190 € (+0,69 %)     SYENSQO 69.700 € (+0,58 %)     SOFINA 233.800 € (+2,01 %)     TITAN S.A. 50.700 € (+3,89 %)  
   SAFRAN 327.300 € (+1,36 %)     BNP PARIBAS ACT.A 106.780 € (+1,54 %)     PLANISWARE 20.050 € (+0,25 %)     PROSUS 37.110 € (-3,60 %)     CRCAM MORBIHAN CCI 110.000 € (-0,09 %)     ENGIE 27.560 € (+1,96 %)     SOCIETE GENERALE 78.060 € (+1,11 %)     BE SEMICONDUCTOR 248.100 € (+3,59 %)     ALFEN 13.550 € (-1,38 %)     TIKEHAU CAPITAL 17.300 € (-0,35 %)     ARTMARKET COM 2.600 € (+11,11 %)     PERNOD RICARD 63.140 € (+0,86 %)     EXOSENS 61.950 € (+2,57 %)     EUROPLASMA 0.001 € (-16,67 %)     SCHNEIDER ELECTRIC 269.000 € (+0,07 %)     ABIONYX PHARMA 1.920 € (+3,00 %)     STELLANTIS NV 5.092 € (+0,20 %)     AIR LIQUIDE 176.740 € (+0,12 %)     STMICROELECTRONICS 58.270 € (+1,78 %)     GRAINES VOLTZ 18.000 € (-0,83 %)     ASM INTERNATIONAL 895.400 € (-0,80 %)     GROUPE OKWIND 0.215 € (-10,42 %)     CROSSJECT 1.544 € (-2,03 %)     MICHELIN 35.010 € (-0,14 %)     ACCOR 46.290 € (-0,15 %)     ASML HOLDING 1 589.600 € (-0,24 %)     WOLTERS KLUWER 59.980 € (-0,03 %)     CARREFOUR 16.650 € (+0,63 %)     TOTALENERGIES 74.290 € (+2,03 %)     ING GROEP N.V. 29.215 € (+0,53 %)     CVC CAPITAL 14.300 € (-0,83 %)     ELIS 25.400 € (+0,79 %)     ADYEN 820.900 € (+0,04 %)     AKZO NOBEL 58.140 € (+1,71 %)     LVMH 474.000 € (-0,95 %)     HERMES INTL 1 679.500 € (-0,09 %)     AIRBUS 208.300 € (+7,04 %)     REXEL 38.210 € (+0,26 %)     LARGO 1.520 € (+4,11 %)     UNILEVER 54.090 € (+1,22 %)     KERING 250.750 € (-0,08 %)     CHRISTIAN DIOR 440.000 € (0,00 %)     RELX 28.880 € (-0,07 %)     RAPID NUTRITION 4.070 € (+13,69 %)     ABIVAX 115.400 € (-1,79 %)     BUREAU VERITAS 27.220 € (+0,59 %)     JCDECAUX 22.140 € (+1,28 %)     L'OREAL 380.650 € (+0,50 %)     FUGRO 9.785 € (+1,19 %)     TELEPERFORMANCE 54.260 € (+1,76 %)     QUADIENT 12.880 € (+0,94 %)     AEGON 8.074 € (+0,67 %)     GTT 192.000 € (+1,27 %)     VALEO 13.310 € (+2,11 %)     AMUNDI 87.900 € (-1,18 %)     DASSAULT SYSTEMES 17.760 € (-0,89 %)     FRANCAISE ENERGIE 27.150 € (-6,38 %)     MAGNUM 15.884 € (+0,43 %)     WORLDLINE 10.050 € (-1,08 %)     ARVERNE GROUP 8.960 € (-0,44 %)  
News Réglementées
21/07/2026 18:50

Soapeya, a DN Group AG Portfolio Company, Earns Top "Excellent" Rating from Dermatest and Proves Successful in Field Use in Ghana

EQS-News: DN Group AG / Key word(s): ESG/Miscellaneous
Soapeya, a DN Group AG Portfolio Company, Earns Top "Excellent" Rating from Dermatest and Proves Successful in Field Use in Ghana

21.07.2026 / 18:50 CET/CEST
The issuer is solely responsible for the content of this announcement.


FRANKFURT AM MAIN, Germany, July 21, 2026 /PRNewswire/ -- DN Group AG (ISIN: DE000A3DW408) reports positive recent developments at its portfolio company SW Save the Water GmbH and its product Soapeya. Soapeya has received a thoroughly positive assessment from the independent institute Dermatest, earning the top rating of "excellent." In parallel, the first practical applications of the waterless soap have proven successful during a deployment by the aid organization Plan International in Ghana.

Soapeya Dermatest Bestnote

Dermatest concluded that using Soapeya's waterless soap reliably removes dirt particles and significantly reduces germs without drying out the skin or burdening the environment with artificial additives. The product achieved a significant cleaning performance of 99.5 percent on heavily soiled hands, demonstrating proven technological efficiency compared with a modern liquid soap and water. This makes Soapeya suitable for use even where running water is unavailable.

The ingredients also help preserve the skin's healthy microbiome, which conventional soaps and disinfectants can often damage. A highly complex procedure based on rRNA gene sequencing demonstrated that Soapeya does not attack the skin's natural microbiome and keeps microbial diversity stable. The product has thereby qualified for the "Microbiome-Friendly" seal. Dermatest seals are awarded exclusively to products that are skin-compatible and safe, giving the assessment solid credibility with trading partners, procurement bodies, and end customers.

Furthermore, all of Soapeya's ingredients are biodegradable, as they are based on renewable raw materials. Unlike conventional soaps, the product causes no adverse environmental effects, while delivering very good efficacy and complete water savings. Soapeya thus combines ecological sustainability with measurable dermatological benefits.

The Soapeya products have also begun to establish themselves in practice. During a deployment by the aid organization Plan International in Ghana, the products were tested by the rural population and received consistently positive reviews. Women who perform physically demanding fieldwork benefit in particular, as Soapeya gives them an effective way to maintain hand hygiene and skin care during their work, even when no water is available. According to field experience, Soapeya also noticeably reduced calluses on the hands, and skin cracks receded within a few days. The field deployment thus confirms the laboratory results under real-world conditions.

In the coming months, a broader product roll-out of Soapeya for various applications in national and international markets is planned. The Dermatest assessment and the experience from the deployment in Ghana will serve as evidence of the product's efficacy and skin compatibility for potential partners and customers. DN Group AG supports the portfolio company through this growth as an investor and advisor.

Ole Nixdorff, CEO of DN Group AG: "The latest positive developments at SW Save the Water demonstrate high user-friendliness combined with this holding's positive impact on the environment and water-scarce regions. This once again underscores the value of our impact investment portfolio. The next step is to complement the positive ecological and social impact with economic success. We look forward to supporting the company through its continued growth as an investor and strategic advisor."

About DN Group AG

DN Group AG invests in impact companies with strong growth prospects in future-oriented industries such as AI, mobility, the circular economy, nutrition, health, and energy, and supports them through successful IPOs. DN Group AG is one of the leading providers of advisory services for IPOs and capital market transactions, connecting fast-growing ESG companies with international institutional investors. DN Group AG advises its portfolio partners on all capital market instruments, independently of banks.

Contact: DN Group AG, Frankfurt am Main, Germany Email: info@dn-ag.com 

https://www.linkedin.com/company/deutsche-nachhaltigkeit/
https://www.facebook.com/people/Deutsche-Nachhaltigkeit/61569532033669/

Cision View original content to download multimedia:https://www.prnewswire.com/de/pressemitteilungen/soapeya-a-dn-group-ag-portfolio-company-earns-top-excellent-rating-from-dermatest-and-proves-successful-in-field-use-in-ghana-302831099.html

rt.gif?NewsItemId=EN09183&Transmission_Id=202607211248PR_NEWS_EURO_ND__EN09183&DateId=20260721


21.07.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2369560  21.07.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière